US2002051765A1PendingUtilityA1
Method of cancer treatment
Priority: Oct 3, 1989Filed: Dec 19, 2000Published: May 2, 2002
Est. expiryOct 3, 2009(expired)· nominal 20-yr term from priority
Inventors:David S. Terman
C12N 5/0693A61K 2039/55544C12N 2501/23C07K 14/31C07K 14/315C12N 2510/00A61K 38/00A61P 35/00A61P 37/04A61K 40/4532A61K 40/10A61K 2239/38C12N 5/0636
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Treatment of solid tumors, including their metastases, without radiation, surgery or standard chemotherapeutic agents is described. Ex vivo stimulation of cells, selection of specific Vβ subsets of stimulated cells and reinfusion of the Vβ subsets of stimulated cells is employed for cancer therapy.
Claims
exact text as granted — not AI-modified1 . A method for inducing a tumoricidal reaction in vivo comprising contacting cells with superantigens ex vivo, selecting a specific Vβ subset of stimulated cells and infusing them into a tumor-bearing host.
2 . A method of human cancer treatment comprising:
a) providing a human cancer patient; b) obtaining hematopoietic cells from said patient; c) contacting said cells ex vivo with one or more superantigens to generate stimulated cells; d) selecting a specific Vβ subset of said cells; and e) re-introducing said Vβ subset of cells into said patient so as to induce an in vivo therapeutic, tumoricidal reaction.
3 . A reagent for treating cancer, comprising a specific Vβ subset of T cells sensitized to a growing tumor and stimulated with superantigens.
4 . A method of human cancer treatment comprising:
a) providing a human cancer patient; b) obtaining hematopoietic cells from said patient; c) contacting said cells ex vivo with one or more superantigens to generate stimulated cells; d) depleting a specific Vβ subset of said cells said Vβ subset having suppressor effects on tumoricidal activity; and e) re-introducing said stimulated cells depleted of said Vβ subset into said patient so as to induce an in vivo therapeutic, tumoricidal reaction.Join the waitlist — get patent alerts
Track US2002051765A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.